Our products are currently within the development cycle. Our future pipeline focuses on technology that reduces drug overdose through connectivity.
Our signature product is the Naloxone Exchange, and we expect a launch date of late Fall 2018. We have a feature prototype for a consumer product Naloxone Tracker which has been entered in the FDA #NaloxoneApp competition. We are also creating an Industry crowdsourcing platform for health professionals (Jaws). Check back, for updates!
- Team Fiduscript.